Literature DB >> 34283369

Predictive factors of postoperative diabetes insipidus in 333 patients undergoing transsphenoidal surgery for non-functioning pituitary adenoma.

Yasuyuki Kinoshita1,2,3, Akira Taguchi4,5,6, Atsushi Tominaga4,5,6, Tetsuhiko Sakoguchi4,5,6, Kazunori Arita4,5,6, Fumiyuki Yamasaki4,5,6.   

Abstract

PURPOSE: Diabetes insipidus (DI) following transsphenoidal surgery (TSS) is a common complication. Although postoperative DI often occurs in patients with craniopharyngioma and Rathke's cleft cyst, postoperative DI in patients with non-functioning pituitary adenoma (NFPA) has not been fully examined. We clarified the clinical characteristics and magnetic resonance imaging (MRI) findings predicting postoperative DI in NFPAs.
METHODS: A total of 333 patients undergoing initial TSS for NFPA were included in this retrospective study. Hyperintensity (HI) in the posterior pituitary lobe was evaluated on preoperative T1-weighted MRI. Based on the findings of HI patients were divided into three groups as follows: HI was not detected (Disappearance group), HI located intrasellarly (Intrasellar group), and HI located suprasellarly (Suprasellar group).
RESULTS: The overall rate of DI was 21.9%, including permanent DI in 0.6%. DI occurred at postoperative day 1 (72.6%) or day 2 (19.2%) and improved within 7 days in most cases (87.7%). Univariable and multivariable analyses showed that the predictive factors of DI were a younger age (odds ratio [OR] 0.97, 95% confidence interval [CI] 0.95-0.99, P = 0.0037) and larger tumor diameter (OR 1.04, 95% CI 1.01-1.08, P = 0.0155). The rate of DI was highest in the Disappearance group (43.8%) followed by the Intrasellar group (26.0%). The OR was 2.17 in the Intrasellar group compared with the Suprasellar group (95% CI 1.17-4.02, P = 0.0141).
CONCLUSIONS: Factors predicting DI following TSS for NFPA were a younger age, larger tumor size, and the location of intrasellar HI on preoperative T1-weighted MRI.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Diabetes insipidus; Non-functioning pituitary adenoma; Pituitary; Posterior pituitary lobe; Transsphenoidal surgery

Mesh:

Year:  2021        PMID: 34283369     DOI: 10.1007/s11102-021-01175-y

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  21 in total

1.  Bright pituitary stalk on MR T1-weighted image: damming up phenomenon of the neurosecretory granules.

Authors:  Ichiro Fujisawa; Kyosuke Uokawa; Naotoshi Horii; Norihiko Murakami; Nobuyuki Azuma; Sumiko Furuto-Kato; Kohsuke Yamashita; Satoshi Nakao; Naoki Kageyama
Journal:  Endocr J       Date:  2002-04       Impact factor: 2.349

2.  Prediction of postoperative diabetes insipidus using morphological hyperintensity patterns in the pituitary stalk on magnetic resonance imaging after transsphenoidal surgery for sellar tumors.

Authors:  Yasuhiko Hayashi; Daisuke Kita; Takuya Watanabe; Issei Fukui; Yasuo Sasagawa; Masahiro Oishi; Osamu Tachibana; Fumiaki Ueda; Mitsutoshi Nakada
Journal:  Pituitary       Date:  2016-12       Impact factor: 4.107

3.  Disorders of water metabolism following transsphenoidal pituitary surgery: a single institution's experience.

Authors:  Jessica R Adams; Lewis S Blevins; George S Allen; Denise K Verity; Jessica K Devin
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

4.  Diabetes insipidus and syndrome of inappropriate antidiuresis (SIADH) after pituitary surgery: incidence and risk factors.

Authors:  Elena L Sorba; Victor E Staartjes; Stefanos Voglis; Lazar Tosic; Giovanna Brandi; Oliver Tschopp; Carlo Serra; Luca Regli
Journal:  Neurosurg Rev       Date:  2020-06-24       Impact factor: 3.042

5.  Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients.

Authors:  Edward C Nemergut; Zhiyi Zuo; John A Jane; Edward R Laws
Journal:  J Neurosurg       Date:  2005-09       Impact factor: 5.115

6.  Post-operative diabetes insipidus after endoscopic transsphenoidal surgery.

Authors:  Matthew Schreckinger; Blake Walker; Jordan Knepper; Mark Hornyak; David Hong; Jung-Min Kim; Adam Folbe; Murali Guthikonda; Sandeep Mittal; Nicholas J Szerlip
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

7.  Diabetes Insipidus following Endoscopic Transsphenoidal Surgery for Pituitary Adenoma.

Authors:  Abdulrazag M Ajlan; Sarah Bin Abdulqader; Achal S Achrol; Yousef Aljamaan; Abdullah H Feroze; Laurence Katznelson; Griffith R Harsh
Journal:  J Neurol Surg B Skull Base       Date:  2017-08-03

8.  Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study.

Authors:  Rudolf A Kristof; Maria Rother; Georg Neuloh; Dietrich Klingmüller
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

9.  Is it possible to predict the development of diabetes insipidus after pituitary surgery? Study of 241 endoscopic transsphenoidal pituitary surgeries.

Authors:  M Araujo-Castro; F Mariño-Sánchez; A Acitores Cancela; A García Fernández; S García Duque; V Rodríguez Berrocal
Journal:  J Endocrinol Invest       Date:  2020-10-11       Impact factor: 4.256

10.  Predictors of Postoperative Diabetes Insipidus Following Endoscopic Resection of Pituitary Adenomas.

Authors:  Pratima Nayak; Alaa S Montaser; Jie Hu; Daniel M Prevedello; Lawrence S Kirschner; Luma Ghalib
Journal:  J Endocr Soc       Date:  2018-07-27
View more
  2 in total

Review 1.  Diagnosis and Management of Central Diabetes Insipidus in Adults.

Authors:  Maria Tomkins; Sarah Lawless; Julie Martin-Grace; Mark Sherlock; Chris J Thompson
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

Review 2.  Current Advances in the Management of Adult Craniopharyngiomas.

Authors:  Montserrat Lara-Velazquez; Yusuf Mehkri; Eric Panther; Jairo Hernandez; Dinesh Rao; Peter Fiester; Raafat Makary; Michael Rutenberg; Daryoush Tavanaiepour; Gazanfar Rahmathulla
Journal:  Curr Oncol       Date:  2022-03-04       Impact factor: 3.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.